{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:42:48Z","timestamp":1780940568969,"version":"3.54.1"},"reference-count":54,"publisher":"SLACK, Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychosoc Nurs Ment Health Serv"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>\n            Stimulant use disorders are emerging as a serious global threat to health. Although research, clinical, and policy efforts have largely concentrated on opioid use disorders over the past decade, exponential rises in prevalence and overdose deaths attributable to stimulant use disorders warrant renewed attention. To date, no approved medications are available to treat stimulant use disorders; however, behavioral interventions have been effective and should be proactively promoted. Similarly, complementary and integrative therapies and harm reduction services have emerging evidence for effectiveness in treating these conditions. Research, practice, and policy interventions should address stigma for medications for stimulant use disorders when available, vaccine hesitancy if vaccines are approved and safe, environmental surveillance to reduce population exposure to toxic effects of methamphetamines, and educational interventions for health providers to increase competency to reduce the long-term effects on various body systems. [\n            <jats:italic>Journal of Psychosocial Nursing and Mental Health Services, 61<\/jats:italic>\n            (3), 13\u201318.]\n          <\/jats:p>","DOI":"10.3928\/02793695-20230215-03","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T21:15:09Z","timestamp":1678223709000},"page":"13-18","source":"Crossref","is-referenced-by-count":1,"title":["Are We Witnessing a New Wave of Substance Use Disorders?: A Spotlight on Stimulant Use Disorders"],"prefix":"10.3928","volume":"61","author":[{"given":"Mercy Ngosa","family":"Mumba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_1_3_1","author":"American Psychological Association","year":"2017","unstructured":"American Psychological Association. (2017). What is cognitive behavioral therapy? https:\/\/www.apa.org\/ptsd-guideline\/patients-and-families\/cognitive-behavioral","journal-title":"What is cognitive behavioral therapy?"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt243"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.03.019"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567270000906010030"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000830"},{"key":"e_1_3_1_8_1","author":"Centers for Disease Control and Prevention","year":"2019","unstructured":"Centers for Disease Control and Prevention. (2019). Syringe services programs (SSPs) fact sheet. https:\/\/www.cdc.gov\/ssp\/syringe-services-programs-factsheet.html","journal-title":"Syringe services programs (SSPs) fact sheet"},{"key":"e_1_3_1_9_1","author":"Centers for Disease and Control Prevention","year":"2020","unstructured":"Centers for Disease and Control Prevention. (2020a). HIV and injection drug use. https:\/\/www.cdc.gov\/hiv\/basics\/hiv-transmission\/injection-drug-use.html#:\u223c:text=The%20risk%20for%20getting%20or,and%20blood%20can%20carry%20HIV","journal-title":"HIV and injection drug use"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. (2020b). Patterns and characteristics of methamphetamine use among adults\u2014United States 2015\u20132018 . https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6912a1.htm","DOI":"10.15585\/mmwr.mm6912a1"},{"key":"e_1_3_1_11_1","author":"Centers for Disease Control and Prevention","year":"2022","unstructured":"Centers for Disease Control and Prevention. (2022). HIV and people who inject drugs. https:\/\/www.cdc.gov\/hiv\/group\/hiv-idu.html","journal-title":"HIV and people who inject drugs"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ppc.12082"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00084"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.10.027"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.747787"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002715"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0941"},{"key":"e_1_3_1_18_1","unstructured":"Delphi Behavioral Health Group. (2022). Meth use statistics around the world (2019) . https:\/\/delphihealthgroup.com\/stimulants\/methamphetamine\/global-use-statistics\/"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-009-0777-y"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2014.07.009"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13091883"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2011.0338"},{"key":"e_1_3_1_23_1","first-page":"299","volume-title":"Psychotherapy for the advanced practice psychiatric nurse: A how-to guide for evidence-based practice","author":"Hamera E","year":"2014","unstructured":"Hamera, E. (2014). Motivational interviewing. In Wheeler K. (Ed.), Psychotherapy for the advanced practice psychiatric nurse: A how-to guide for evidence-based practice (2nd ed., pp. 299\u2013312). Springer.","edition":"2"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312461"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.4103\/jnrp.jnrp_243_17"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jclp.20673"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-015-9888-y"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.03.014"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S138439"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780190275334.003.0007"},{"key":"e_1_3_1_31_1","author":"National Institute on Drug Abuse","year":"2018","unstructured":"National Institute on Drug Abuse. (2018). Five million American adults misusing prescription stimulants. https:\/\/nida.nih.gov\/news-events\/news-releases\/2018\/04\/five-million-american-adults-misusing-prescription-stimulants","journal-title":"Five million American adults misusing prescription stimulants"},{"key":"e_1_3_1_32_1","author":"National Institute on Drug Abuse","year":"2019","unstructured":"National Institute on Drug Abuse. (2019). Methamphetamine drug facts. https:\/\/nida.nih.gov\/publications\/drugfacts\/methamphetamine","journal-title":"Methamphetamine drug facts"},{"key":"e_1_3_1_33_1","author":"National Institute on Drug Abuse","year":"2021","unstructured":"National Institute on Drug Abuse. (2021). Cocaine drug facts. https:\/\/nida.nih.gov\/publications\/drugfacts\/cocaine","journal-title":"Cocaine drug facts"},{"key":"e_1_3_1_34_1","author":"National Institute on Drug Abuse","year":"2022","unstructured":"National Institute on Drug Abuse. (2022). Overdose death rates. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates","journal-title":"Overdose death rates"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229208"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.08.007"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108245"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2013.02.005"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(09)88011-2"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.281"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5514873"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2564"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.06.041"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11609"},{"key":"e_1_3_1_45_1","author":"Statista","year":"2022","unstructured":"Statista. (2022). Number of cocaine users worldwide from 2010 to 2020, by region. https:\/\/www.statista.com\/statistics\/264738\/number-of-worldwide-users-of-cocaine-by-region\/","journal-title":"Number of cocaine users worldwide from 2010 to 2020, by region"},{"key":"e_1_3_1_46_1","author":"Substance Abuse and Mental Health Services Administration","year":"2020","unstructured":"Substance Abuse and Mental Health Services Administration. (2020). Evidence-based resource guide series\u2014Treatment of stimulant use disorders. https:\/\/store.samhsa.gov\/sites\/default\/files\/pep20-06-01-001.pdf","journal-title":"Evidence-based resource guide series\u2014Treatment of stimulant use disorders"},{"key":"e_1_3_1_47_1","author":"Substance Abuse and Mental Health Services Administration","year":"2022","unstructured":"Substance Abuse and Mental Health Services Administration. (2022). Harm reduction. https:\/\/www.samhsa.gov\/find-help\/harm-reduction","journal-title":"Harm reduction"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03178267"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.18356\/9789210019545"},{"key":"e_1_3_1_50_1","author":"U.S. Food and Drug Administration","year":"2020","unstructured":"U.S. Food and Drug Administration. (2020). Public meeting on patient-focused drug development for stimulant use disorder. https:\/\/www.fda.gov\/media\/143403\/download","journal-title":"Public meeting on patient-focused drug development for stimulant use disorder"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.3.377"},{"key":"e_1_3_1_52_1","author":"Washington State Department of Health","year":"2022","unstructured":"Washington State Department of Health. (2022). Meth labs. https:\/\/doh.wa.gov\/community-and-environment\/contaminants\/drug-labs\/meth-labs","journal-title":"Meth labs"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2021.1936051"},{"issue":"1206","key":"e_1_3_1_54_1","first-page":"U1180","article-title":"Maternal methamphetamine use during pregnancy and child outcome: What do we know?","volume":"117","author":"Wouldes T.","year":"2004","unstructured":"Wouldes, T., LaGasse, L., Sheridan, J., & Lester, B. (2004). Maternal methamphetamine use during pregnancy and child outcome: What do we know? The New Zealand Medical Journal, 117(1206), U1180. PMID:15570349","journal-title":"The New Zealand Medical Journal"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000101"}],"container-title":["Journal of Psychosocial Nursing and Mental Health Services"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:43:58Z","timestamp":1683110638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/02793695-20230215-03"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.3928\/02793695-20230215-03"],"URL":"https:\/\/doi.org\/10.3928\/02793695-20230215-03","relation":{},"ISSN":["0279-3695","1938-2413"],"issn-type":[{"value":"0279-3695","type":"print"},{"value":"1938-2413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}